← Evidence map

ArticleInternational journal of nephrology and renovascular disease2021

Validity of Urinary Monoamine Assay Sales Under the "Spot Baseline Urinary Neurotransmitter Testing Marketing Model" [Retraction].

PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 33688236